stella
beta
Find trials matched to me
Trial Match
Prevention of Postoperative Recurrence of Hepatocellular Carcinoma by Blocking RAK Cells With Anti-TIM-3 — Stella
Recruiting
Back to Hepatocellular Carcinoma trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Trial locations
(1 site)
China
Beijing Hospital Center of Biotherapy, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov